16
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      Are you tired of sifting through news that doesn't interest you?
      Personalize your Karger newsletter today and get only the news that matters to you!

      Sign up

      • Record: found
      • Abstract: found
      • Article: found

      Acanthamoeba Keratitis

      review-article
      Ophthalmologica
      S. Karger AG
      Treatment, Prevention, <italic>Acanthamoeba</italic> keratitis, Epidemiology, Diagnosis

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The first Acanthamoeba keratitis was found in 1974, and the first Japanese case was reported in 1988. We devided the clinical features to three stages, and described clinical features in each stage. Diagnosis was suspected from clinical history and features, and definite diagnosis was made by direct examination or culture. We recommended the triple procedures consisted from systemic antifungal drug, topical anti-amoebic eye drops, and surgical debridement of the lesion for optimal treatment of Acanthamoeba keratitis. Prevention must be aimed at education of eye care practitioners and contact lens wearers.

          Related collections

          Author and article information

          Journal
          OPH
          Ophthalmologica
          10.1159/issn.0030-3755
          Ophthalmologica
          S. Karger AG
          0030-3755
          1423-0267
          1997
          1997
          01 April 2010
          : 211
          : Suppl 1
          : 39-44
          Affiliations
          Department of Ophthalmology, Tokyo Women&rsquo;s Medical College, Daini Hospital, Tokyo, Japan
          Article
          310885 Ophthalmologica 1997;211:39–44
          10.1159/000310885
          9065937
          c138425c-b784-4e30-a8f7-f6e45e5bf719
          © 1997 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 6
          Categories
          Paper

          Vision sciences,Ophthalmology & Optometry,Pathology
          Prevention,Treatment,<italic>Acanthamoeba</italic> keratitis,Epidemiology,Diagnosis

          Comments

          Comment on this article